Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00754546 · ClinicalTrials.gov registry record · Phase 4
Effect of Bronchodilation on Cycle vs Treadmill Exercise Endurance Time in COPD
A Phase 4 study, sponsored by Dartmouth-Hitchcock Medical Center.
- Completed
- Registry status
- Phase 4
- Development phase
- 20
- Enrollment target
NCT00754546 is a Phase 4 study that has completed, run by Dartmouth-Hitchcock Medical Center. The registered enrollment target is 20 participants.
The verdict
NCT00754546, a Phase 4 study, has completed, sponsored by Dartmouth-Hitchcock Medical Center.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 20 participants
- Enrollment target
Study Summary
Previous studies suggest that treadmill exercise may be a more relevant exercise stimulus than the cycle ergometer to demonstrate benefits with bronchodilator therapy in patients with COPD. The hypothesis of the study is that patients with COPD will exhibit greater improvements in exercise endurance and breathlessness with arformoterol compared with normal saline during treadmill walking than with cycle exercise.
Interventions
- OTHER Treadmill Exercise
- DRUG Arformoterol tartrate
- DRUG Placebo: Normal Saline
- OTHER Cycle Exercise
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2008-08 |
| Est. Completion | 2009-05 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00754546
The ClinicalTrials.gov registry entry for NCT00754546 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Dartmouth-Hitchcock Medical Center, which has 427 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which Treadmill Exercise is the first listed.
NCT00754546 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00754546 about?
NCT00754546 is a clinical study titled "Effect of Bronchodilation on Cycle vs Treadmill Exercise Endurance Time in COPD". Previous studies suggest that treadmill exercise may be a more relevant exercise stimulus than the cycle ergometer to demonstrate benefits with bronchodilator therapy in patients with COPD. The hypothesis of the study is that patients with COPD will exhibit greater improvements in exercise endurance...
What is the current status of trial NCT00754546?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 20 participants. The study started on 2008-08. Estimated completion is 2009-05.
What interventions are being tested in trial NCT00754546?
The interventions under investigation include: Treadmill Exercise (OTHER), Arformoterol tartrate (DRUG), Placebo: Normal Saline (DRUG), Cycle Exercise (OTHER).
Who is sponsoring clinical trial NCT00754546?
This trial is sponsored by Dartmouth-Hitchcock Medical Center, which has 427 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.